Annovis Bio, Inc. (ANVS) stock
ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.74−0.01 (-0.91%)
Close on Nov 17, 2026Market cap $31.66MP/E –Yield –
Annovis Bio price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Annovis Bio's price to book ratio was 16.0× on Jul 31, 2026, against 2.2× a year earlier. Over the last 5 years it ranged from 1.7× to 136.1×, with a median of 4.2×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 16.0× | +10.7 |
| 2025 | Dec 31, 2025 | 5.3× | −4.1 |
| 2024 | Dec 31, 2024 | 9.5× | −15.9 |
| 2023 | Dec 29, 2023 | 25.3× | +22.1 |
| 2022 | Dec 30, 2022 | 3.2× | +0.1 |
| 2021 | Dec 31, 2021 | 3.1× | −2.6 |
| 2020 | Dec 31, 2020 | 5.7× | – |
See a number that looks wrong?